Pharma companies settle M&A dispute
Multinational pharmaceutical companies Teva and Allergan have agreed a US$700 million settlement of a dispute over the value of a generic drug business that Teva acquired in a US$40.5 billion deal.
To read more
Subscribe to Global Arbitration Review
Subscribe and start reading now
Global Arbitration Review (GAR) is the online home for international arbitration specialists, telling them everything they need to know about all the developments that matter.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10